Non-traditional settings for influenza vaccination of adults: Costs and cost effectiveness

Medicine & Life Sciences

• Human Influenza 82%
• Cost-Benefit Analysis 77%
• Vaccination 71%
• Costs and Cost Analysis 55%
• Mass Vaccination 35%
• Office Visits 32%
• Pharmacies 22%
• Insurance Benefits 13%
• Pharmacy 12%
• Health Care Costs 11%
• Vaccines 9%
• Decision Trees 7%
• Vaccination Coverage 7%
• Cost of Illness 7%
• Health Services Needs and Demand 7%
• Pharmacists 6%
• Workplace 6%
• Organizations 5%
• Outpatients 4%
• Hospitalization 4%
• Age Groups 4%
• Interviews 4%
• Morbidity 3%
• Incidence 3%

Social Sciences

• vaccination 100%
• contagious disease 87%
• costs 50%
• illness 7%
• adverse events 6%
• telephone interview 5%
• pharmacist 5%
• hospitalization 5%
• morbidity 4%
• health 4%
• incidence 3%
• recipient 3%
• coverage 3%
• death 3%
• time 1%
• Group 1%